Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06603571
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
A Study to Investigate Weight Management With LY3841136 and Tirzepatide LY3298176 Alone or in Combination in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 2 Parallel-Group Double-Blind Placebo-Controlled Study to Investigate Weight Management With LY3841136 and Tirzepatide Alone or in Combination in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study performed under the master protocol W8M-MC-CWMM NCT06143956 is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes Participation in the study will last about 64 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None